How effective is infliximab?
Infliximab reduces signs and symptoms of rheumatoid arthritis and prevents joint damage. It has also been shown to improve the physical function of joints, thus enabling RA sufferers to have an increased quality of life. Clinical trials of large numbers of patients have shown on X-rays that infliximab slows down the progression of rheumatoid arthritis. Associate Professor Geoff McColl, Consultant Rheumatologist at Royal Melbourne Hospital, said: ‘With Remicade, we have a treatment that significantly reduces the joint damage caused by rheumatoid arthritis and returns sufferers to a more normal, daily routine. These are our main treatment goals in this insidious disease and at present, those with severe disease are most likely to benefit from this medication.
